Plasma ctDNA monitoring during epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor treatment in patients with EGFR -mutant non-small cell lung cancer (JP-CLEAR trial).
- Resource Type
- Article
- Source
- Japanese Journal of Clinical Oncology; Jun2019, Vol. 49 Issue 6, p554-558, 5p
- Subject
- Language
- ISSN
- 03682811